Kendric Cromer, 12, is among the first patients to be treated with the newly FDA-approved gene therapy, while many other patients have difficulty accessing it.
Kendric Cromer, 12, is among the first patients to be treated with the newly FDA-approved gene therapy, while many other patients have difficulty accessing it.